Amélioration à long terme de la qualité de vie et des résultats rapportés par les patients avec garadacimab dans le traitement de l’angio-œdème héréditaire : étude d’extension de phase 3 en ouvert

Authors: Chapdelaine, H., Sitz, K., Karelaris, C.H., Guilarte, M., Longhurst, H., Lawo, J.P., Braverman, J., Lumry, W.R.

Source: In La revue de médecine interne December 2024 45 Supplement 2:A551-A552

An experimental design applied to vineyards for identifying spatially and temporally variable crop parameters

Authors: Schoedl, K., Lawo, J.P., Astutiningsih, N.T., Forneck, A.

Source: VITIS -GEILWEILERHOF-. 51(2):53-60

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN311306387&indx=1&recIds=ETOCRN311306387

20. Practical application of subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy – results from a multicenter, randomized, double-blind, placebo-controlled trial (The PATH Study)

Authors: Schaik, I.N., Bril, V., Geloven, N., Hartung, H.P., Lewis, R.A., Sobue, G., Lawo, J.P., Mielke, O., Durn, B.L., Cornblath, D.R., Merkies, I.S.J., Dimachkie, M.M.

Source: Clinical neurophysiology. 131(3):e9-e9

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100097925232.0x000001&indx=1&recIds=ETOCvdc_100097925232.0x000001

PRO65 INDIRECT COMPARISON BETWEEN HUMAN C1-INHIBITOR (C1-INH) SUBCUTANEOUS TREATMENT AND LANADELUMAB FOR ROUTINE PREVENTION OF HEREDITARY ANGIOEDEMA (HAE) ATTACKS

Authors: Fridman, M., Supina, D., Lawo, J.P.

Source: Value in health. 23(1):S340-S340

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100115332620.0x000001&indx=1&recIds=ETOCvdc_100115332620.0x000001

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: the Path study

Authors: van Schaik, I.N., Bril, V., van Geloven, N., Hartung, H.P., Lewis, R.A., Sobue, G., Lawo, J.P., Praus, M., Mielke, O., Durn, B.L., Cornblath, D.R., Merkies, I.S.J.

Source: Journal of the neurological sciences. 381:59-59

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100060928751.0x000001&indx=1&recIds=ETOCvdc_100060928751.0x000001